Altitude Accelerator Client Induce Biologics Secures $2M Financing

Induce Biologics Receives Financing from Belmore Capital February 27, 2015 (Palo Alto, California and Toronto, Canada): Induce Biologics Inc. (“Induce”), a pioneer in bone regenerative medicine research, announced today that the company has closed a financing with Belmore Capital, who has committed to invest $2 million and an option to additionally invest into Induce as… Continue reading Altitude Accelerator Client Induce Biologics Secures $2M Financing